Pfizer is looking to raise the price of its COVID-19 vaccines in the United States by up to four times once Washington’s purchase program ends, according to the company’s U.S. president, Angela Lukin. Pfizer’s COVID-19 vaccine is presently provided free for all Americans by the U.S. government. Next year, when the U.S. public health emergency expires, the COVID-19 vaccine market will move to private insurance [$30 – $130 appx.]. …Many experts were expecting the number of annual COVID-19 shots to be in line with the annual flu vaccine. In the United States, 160 million flu shots are administered every year. However, as many Americans are becoming reluctant to get COVID-19 shots, expectations of market size have tempered.
